Association of Acute Interstitial Nephritis with Nivolumab in Renal Cell Carcinoma: A Case Report

Recently, a number of innovative anticancer agents such us the programmed death 1 (PD-1) immune checkpoint inhibitors have been developed. Nevertheless, this type of immunotherapy may be associated with immune-related adverse events whose pathophysiology is considered similar to those found in autoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Noto-Kadou-Kaza, Befa, Desbuissons, Geoffroy, Isnard, Corinne Bagnis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330651/
https://www.ncbi.nlm.nih.gov/pubmed/34376950
http://dx.doi.org/10.4103/ijn.IJN_62_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330651/
https://www.ncbi.nlm.nih.gov/pubmed/34376950
http://dx.doi.org/10.4103/ijn.IJN_62_20

Ejemplares similares